Nothing Special   »   [go: up one dir, main page]

NO20023985L - Fremgangsmate for rensing av hCG og rekombinant hCG ved denne fremgangsmaten - Google Patents

Fremgangsmate for rensing av hCG og rekombinant hCG ved denne fremgangsmaten

Info

Publication number
NO20023985L
NO20023985L NO20023985A NO20023985A NO20023985L NO 20023985 L NO20023985 L NO 20023985L NO 20023985 A NO20023985 A NO 20023985A NO 20023985 A NO20023985 A NO 20023985A NO 20023985 L NO20023985 L NO 20023985L
Authority
NO
Norway
Prior art keywords
hcg
recombinant
purification
ion
purifying
Prior art date
Application number
NO20023985A
Other languages
English (en)
Other versions
NO328694B1 (no
NO20023985D0 (no
Inventor
Gianfranco Paradisi
Mara Rossi
Laura Scaglia
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20023985L publication Critical patent/NO20023985L/no
Publication of NO20023985D0 publication Critical patent/NO20023985D0/no
Publication of NO328694B1 publication Critical patent/NO328694B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20023985A 2000-02-22 2002-08-21 Fremgangsmate for fremstilling av rekombinant hCG med spesifikk biologisk aktivitet fra en prove NO328694B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00103690 2000-02-22
PCT/EP2001/000665 WO2001062773A1 (en) 2000-02-22 2001-01-22 PROCESS OF PURIFICATION OF hCG AND RECOMBINANT hCG PURIFIED BY THAT METHOD

Publications (3)

Publication Number Publication Date
NO20023985L true NO20023985L (no) 2002-08-21
NO20023985D0 NO20023985D0 (no) 2002-08-21
NO328694B1 NO328694B1 (no) 2010-04-26

Family

ID=8167925

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023985A NO328694B1 (no) 2000-02-22 2002-08-21 Fremgangsmate for fremstilling av rekombinant hCG med spesifikk biologisk aktivitet fra en prove

Country Status (32)

Country Link
US (2) US7297777B2 (no)
EP (2) EP1752466A3 (no)
JP (1) JP4588960B2 (no)
KR (1) KR100806911B1 (no)
CN (1) CN100482679C (no)
AT (1) ATE406378T1 (no)
AU (2) AU783320B2 (no)
BG (1) BG65807B1 (no)
BR (1) BRPI0108556B8 (no)
CA (1) CA2399020A1 (no)
CY (1) CY1108460T1 (no)
CZ (1) CZ303144B6 (no)
DE (1) DE60135541D1 (no)
DK (1) DK1257564T3 (no)
EA (1) EA006605B1 (no)
EE (1) EE05644B1 (no)
ES (1) ES2307585T3 (no)
HK (1) HK1052016A1 (no)
HR (1) HRP20020650B1 (no)
HU (2) HU228935B1 (no)
IL (2) IL151308A0 (no)
ME (1) ME00296B (no)
MX (1) MXPA02007871A (no)
NO (1) NO328694B1 (no)
PL (1) PL205149B1 (no)
PT (1) PT1257564E (no)
RS (1) RS50741B (no)
SI (1) SI1257564T1 (no)
SK (1) SK287146B6 (no)
UA (2) UA86938C2 (no)
WO (1) WO2001062773A1 (no)
ZA (1) ZA200206109B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0108556B8 (pt) * 2000-02-22 2021-05-25 Applied Res Systems Ars Holding N V processo para purificação de gonadotropina coriônica humana recombinante (hcg).
ES2344657T3 (es) * 2004-10-04 2010-09-02 Novetide, Ltd. Procedimiento de intercambio de contraion para peptidos.
CN1958603B (zh) * 2005-11-04 2010-05-05 上海天伟生物制药有限公司 一种人绒毛膜促性腺素的纯化方法
WO2008007993A1 (fr) * 2006-07-11 2008-01-17 Koval, Anton Alexandrovich Utilisation d'une hormone chorionique ou lutéinisante destinée à la prévention ou au traitement de l'hypogonadisme lié à l'âge
CN101397339B (zh) * 2008-09-24 2012-07-25 上海天伟生物制药有限公司 糖蛋白中去除/灭活病毒的方法
TWI604850B (zh) 2009-10-05 2017-11-11 菲瑞茵國際中心股份有限公司 藥學製劑
CN101792481B (zh) * 2010-03-12 2012-05-30 丽珠医药集团股份有限公司 一种绒毛膜促性腺激素的纯化方法
WO2012120535A2 (en) * 2011-02-03 2012-09-13 Sanzyme Limited A composition comprising highly purified chorionic gonadotropin, it's formulation and uses of the same
US9757469B2 (en) 2011-03-31 2017-09-12 Ferring B.V. Pharmaceutical preparation
WO2013102921A2 (en) * 2011-11-17 2013-07-11 Sanzyme Limited Hcg - newer treatment modality for type 2 diabetes mellitus (t2dm)
CN103288950A (zh) * 2012-12-28 2013-09-11 青岛九龙生物医药有限公司 改进柱分离工序洗涤液和洗脱液配比去除杂质的方法
CN104101656A (zh) * 2013-04-01 2014-10-15 上海天伟生物制药有限公司 一种促性腺激素的纯度测定方法
US20150065426A1 (en) * 2013-08-27 2015-03-05 Professional Compounding Centers Of America Testosterone Booster Transdermal Compositions
CN105968185A (zh) * 2016-07-20 2016-09-28 宁波人健药业集团股份有限公司 一种绒促性素纯化方法
CN111233999B (zh) * 2020-03-21 2024-02-23 上海浦东明炎生物技术有限公司 一种从人尿中提取人绒毛膜促性腺激素的方法
CN113398251B (zh) * 2021-07-30 2022-08-05 宁波人健药业集团股份有限公司 一种重组人绒毛膜促性腺激素冻干粉针剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69029799T2 (de) 1989-02-21 1997-05-28 Washington University, St. Louis, Mo. Modifizierte formen von fortpflanzungshormonen
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
IT1254370B (it) * 1992-05-22 1995-09-14 Sorin Biomedica Spa Procedimento per la purificazione di proteine da sistemi cellulari.
AU707796B2 (en) 1995-03-21 1999-07-22 Merck Serono Sa HCG liquid formulations
DE69733309T2 (de) * 1996-02-20 2006-01-19 Applied Research Systems Ars Holding N.V. Heterodimerebildende hybrid-proteine
IT1287138B1 (it) * 1996-11-07 1998-08-04 Ibsa Inst Biochimique Sa Procedimento per la separazione e purificazione di fsh e lh
AU8142198A (en) 1997-06-12 1998-12-30 Regents Of The University Of California, The A transcription factor coactivator protein, p/cip
US6121428A (en) * 1997-06-13 2000-09-19 Genentech, Inc. Protein recovery
US6583109B1 (en) * 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
BRPI0108556B8 (pt) * 2000-02-22 2021-05-25 Applied Res Systems Ars Holding N V processo para purificação de gonadotropina coriônica humana recombinante (hcg).

Also Published As

Publication number Publication date
BG65807B1 (bg) 2009-12-31
IL151308A (en) 2009-11-18
MEP38908A (en) 2011-02-10
CA2399020A1 (en) 2001-08-30
ZA200206109B (en) 2003-07-31
ME00296B (me) 2011-05-10
US7297777B2 (en) 2007-11-20
JP4588960B2 (ja) 2010-12-01
BRPI0108556B1 (pt) 2015-04-14
HU1300063D0 (hu) 2003-03-28
PL205149B1 (pl) 2010-03-31
PT1257564E (pt) 2008-09-10
AU2680401A (en) 2001-09-03
US20030104553A1 (en) 2003-06-05
CN100482679C (zh) 2009-04-29
CY1108460T1 (el) 2014-04-09
NO328694B1 (no) 2010-04-26
EE200200469A (et) 2004-04-15
JP2003524015A (ja) 2003-08-12
ES2307585T3 (es) 2008-12-01
CN1404485A (zh) 2003-03-19
AU2006200059A1 (en) 2006-02-02
NO20023985D0 (no) 2002-08-21
DK1257564T3 (da) 2008-10-06
MXPA02007871A (es) 2003-02-10
RS50741B (sr) 2010-08-31
CZ20022855A3 (cs) 2002-11-13
ATE406378T1 (de) 2008-09-15
HK1052016A1 (en) 2003-08-29
KR100806911B1 (ko) 2008-02-22
AU783320B2 (en) 2005-10-13
HU228935B1 (en) 2013-06-28
CZ303144B6 (cs) 2012-05-02
EP1752466A2 (en) 2007-02-14
SK287146B6 (sk) 2010-01-07
YU60202A (sh) 2005-09-19
DE60135541D1 (de) 2008-10-09
WO2001062773A1 (en) 2001-08-30
US20070299001A1 (en) 2007-12-27
EP1752466A3 (en) 2012-10-10
SK12062002A3 (sk) 2002-12-03
HUP0204231A3 (en) 2005-09-28
HUP0204231A2 (hu) 2003-03-28
UA86938C2 (uk) 2009-06-10
HRP20020650B1 (en) 2011-02-28
EA200200892A1 (ru) 2003-02-27
KR20030001359A (ko) 2003-01-06
SI1257564T1 (sl) 2008-12-31
EA006605B1 (ru) 2006-02-24
BR0108556A (pt) 2003-01-28
EP1257564A1 (en) 2002-11-20
BG107000A (en) 2003-04-30
HRP20020650A2 (en) 2004-12-31
EP1257564B1 (en) 2008-08-27
UA78488C2 (en) 2007-04-10
PL357508A1 (en) 2004-07-26
BRPI0108556B8 (pt) 2021-05-25
EE05644B1 (et) 2013-04-15
IL151308A0 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
NO20023985L (no) Fremgangsmate for rensing av hCG og rekombinant hCG ved denne fremgangsmaten
EE200200464A (et) Meetod LH puhastamiseks
PL366364A1 (en) Process for producing peptides by using in vitrotranscription/translation system
DK0906122T3 (da) Aktiverede linkers og fremgangsmåde til at fremstille og oprense disse
BR0010677B1 (pt) processo de purificaÇço de gonadotropinas urinÁrias humanas a partir de gonadotropinas brutas.

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

MK1K Patent expired